IONpath Revenue and Competitors
Estimated Revenue & Valuation
- IONpath's estimated annual revenue is currently $4.8M per year.
- IONpath's estimated revenue per employee is $77,500
- IONpath's total funding is $18M.
Employee Data
- IONpath has 62 Employees.
- IONpath grew their employee count by 38% last year.
IONpath's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | CEO | Reveal Email/Phone |
3 | VP | Reveal Email/Phone |
4 | VP Engineering | Reveal Email/Phone |
5 | VP Pathology | Reveal Email/Phone |
6 | Senior Business Director | Reveal Email/Phone |
7 | Director Scientific Operations | Reveal Email/Phone |
8 | Director Pathology & Spatial Proteomics Research | Reveal Email/Phone |
9 | Manager, Laboratory Operations Team | Reveal Email/Phone |
10 | Executive Chair | Reveal Email/Phone |
IONpath Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.4M | 70 | -8% | $53M | N/A |
#2 | $32.4M | 167 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.8M | 18 | 13% | N/A | N/A |
#5 | $0.8M | 5 | -50% | N/A | N/A |
#6 | $0.8M | 10 | 0% | N/A | N/A |
#7 | $14M | 90 | -12% | N/A | N/A |
#8 | $0.4M | 336 | 10% | $236.7M | N/A |
#9 | $4.8M | 62 | -74% | $160M | N/A |
#10 | $3.7M | 24 | -8% | N/A | N/A |
What Is IONpath?
IONpathâ„¢ is a venture-backed, commercial-stage company, founded by Stanford researchers out of the lab of Dr. Garry Nolan, focused on revolutionizing pathology with Multiplexed Ion Beam Imaging (MIBI) technology. MIBI is a multiplexed imaging platform with unmatched resolution, sensitivity, and throughput.
keywords:N/A
$18M
Total Funding
62
Number of Employees
$4.8M
Revenue (est)
38%
Employee Growth %
N/A
Valuation
N/A
Accelerator
IONpath News
NEW YORK A federal court has dismissed an appeal by Fluidigm in an ongoing patent infringement lawsuit with IonPath.
MENLO PARK, Calif., Aug. 26, 2021 /PRNewswire/ -- Ionpath, Inc., the leader in high-definition spatial proteomics, today announced a new program for biopharmaceutical research organizations interested in piloting spatial phenotyping analyses of tissue samples leveraging the company's Multiplex ...
IONpath, Inc., a Menlo Park, Calif.-based developer of high-definition spatial proteomics, closed a $18m Series B financing. The round was led by Samsara BioCapital, with participation from new investor Bruker Corporation, and existing major investors Genoa Ventures, ND Capital, Paladin Partner ...
MENLO PARK, Calif., Sept. 24, 2020 /PRNewswire/ -- IONpath, Inc., the leader in high-definition spatial proteomics, today announced the close of a $18 million Series B financing led by Samsara BioCapital, and included participation from new investor Bruker Corporation, a global leader in mass ...
Other Companies in Menlo Park
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $17.2M | 62 | 48% | N/A |
#2 | $18.7M | 63 | -3% | N/A |
#3 | $7.7M | 63 | -10% | $25.7M |
#4 | $10.5M | 65 | 14% | N/A |
#5 | $13.3M | 65 | -4% | N/A |